http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110787172-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2019-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110787172-B |
| titleOfInvention | Application of loranthus glycoside in preparing medicine for preventing and treating diabetes and medicine for preventing and treating diabetes |
| abstract | The invention relates to the technical field of medicines, and provides application of loranthus glycoside in preparing a medicine for preventing and treating diabetes and a medicine for preventing and treating diabetes. The loranthus glycoside has obvious hypoglycemic activity and wide application prospect in preparing medicine for preventing and treating diabetes. In addition, the loranthus glycosides have good water solubility and membrane permeability, can easily achieve high blood concentration in vivo, have good bioavailability, are not easy to be metabolized by liver P450 enzyme, are not easy to penetrate through blood brain barrier, have high clearance rate and low toxicity, have good drug properties, and are a novel drug for preventing and treating diabetes. |
| priorityDate | 2019-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 386.